David C. Musch

22.2k total citations · 3 hit papers
310 papers, 11.6k citations indexed

About

David C. Musch is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, David C. Musch has authored 310 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Ophthalmology, 154 papers in Radiology, Nuclear Medicine and Imaging and 72 papers in Epidemiology. Recurrent topics in David C. Musch's work include Glaucoma and retinal disorders (144 papers), Retinal Diseases and Treatments (95 papers) and Corneal surgery and disorders (89 papers). David C. Musch is often cited by papers focused on Glaucoma and retinal disorders (144 papers), Retinal Diseases and Treatments (95 papers) and Corneal surgery and disorders (89 papers). David C. Musch collaborates with scholars based in United States, Brazil and China. David C. Musch's co-authors include Paul R. Lichter, Leslie M. Niziol, Brenda W. Gillespie, Roni M. Shtein, Alan Sugar, Nancy K. Janz, Bartley R. Frueh, William J. Reinhart, Stephen C. Kaufman and Joshua D. Stein and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David C. Musch

299 papers receiving 11.1k citations

Hit Papers

Descemet's Stripping Endothelial Keratoplasty: Safety and... 2009 2026 2014 2020 2009 2011 2021 100 200 300 400

Peers

David C. Musch
Comparison fields: 5 of 162
  • Ophthalmology 8.3k
  • Radiology, Nuclear Medicine and Imaging 6.5k
  • Public Health, Environmental and Occupational Health 2.2k
  • Epidemiology 1.7k
  • Pathology and Forensic Medicine 973
Replace Catey Bunce with:
Catey Bunce United Kingdom
Dennis S.C. Lam Hong Kong
Gui‐Shuang Ying United States
Ingrid U. Scott United States
Sandra S. Stinnett United States
William J. Feuer United States
Charles N. J. McGhee New Zealand
Peter McCluskey Australia
Radhika Tandon India
Mehdi Khabazkhoob Iran
Catey Bunce United Kingdom View profile →
Citations per field, relative to David C. Musch
David C. Musch · 1×
Citations per year, relative to David C. Musch
David C. Musch · 1×

Countries citing papers authored by David C. Musch

Since Specialization
Citations

This map shows the geographic impact of David C. Musch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Musch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Musch more than expected).

Fields of papers citing papers by David C. Musch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Musch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Musch. The network helps show where David C. Musch may publish in the future.

Co-authorship network of co-authors of David C. Musch

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Musch. A scholar is included among the top collaborators of David C. Musch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Musch. David C. Musch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 13
3 0
4 0
5 1
6
Development of a validated patient-reported outcomes measure for retinal dystrophy therapeutics
1
7 3
8
Stepped Medication Use, Associated Symptoms, and Treatment Failure among Participants in the Medication Arm of the Collaborative Initial Glaucoma Treatment Study
2
9
Are outcomes in primary retinal detachment repair related to distance away from an academic medical center
1
10 25
11
Minimally Important Differences in Vision Specific Quality of Life Measures: Information From the CIGTS
1
12
Argon Laser Trabeculoplasty (ALT) after Initial Medicine or Surgery in the Collaborative Initial Glaucoma Treatment Study (CIGTS): Predictive Factors and Need for Further Intervention
1
13
The Effects of Systemic 1-Adrenoreceptor Antagonists on Pupil Diameter
1
14
Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgery
5
15
Results From the TTT4CNV Clinical Trial
14
16
Prevalence of Sleep Apnea in Patients With Central Serous Chorioretinopathy
1
17
Thinner Central Corneas in Eyes with More Advanced Glaucomatous Cupping – A New Clue to Glaucoma?
2
18
Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial.
47
19
For the patient. Eye screening can prevent eye disease. Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial.
6
20
A randomized pilot study comparing subthreshold vs threshold diode laser photocoagulation (PC) in the reduction of drusen associated with age-related macular degeneration
6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026